Alacrita Life Science Consulting Alacrita Life Science Consulting
  • Our Services
    • Product Development
      • Research & IP Evaluation
      • Preclinical Strategy & Execution
      • Clinical Development
      • Regulatory Affairs
      • CMC Consulting
      • Interim Chief Medical Officer
    • Strategy & Commercialization
      • Opportunity Mapping
      • Business Plans & Fundraising Support
      • New Product Planning
      • Launch Planning
    • Business Development
      • Due Diligence
      • Valuations
      • In-Licensing & Asset Scouting
      • Out-Licensing, Partnering & Deal-making
    • Expert Witness Services
    • By Client Type
      • Biotech
      • Virtual & Semi-Virtual Biotechs
      • Pharmaceutical Companies
      • Investors
      • Tech Transfer Offices
      • Animal Health Companies
    • By Product Modality
      • Antibodies, ADCs
      • Cell Therapies
      • Drug Discovery Platforms
      • Gene Therapies
      • Microbiome Drugs
      • Peptides & Proteins
      • Radiopharmaceuticls
      • Small Molecules
      • Other Product Modalities
    • By Disease Area
      • CNS
      • Digestive & GI
      • Endocrine & Metabolic
      • Fibrosis
      • Hematology
      • Immunology
      • Oncology
      • Respiratory
      • Other Disease Areas
  • Core Team
    • Alastair Southwell
    • Anthony Walker
    • Saadia Anastasiou
    • Michael Lombardo
    • Lucas Rodriguez
    • Mark Philip
    • Nigel Burns
    • Gary Mansfield
    • Christine McCarthy
    • Stuart Hendry
    • Simon Turner
    • Pierre Dodion
  • Consulting Network
  • Resources
    • Case Studies
    • Blog
    • News
    • Whitepapers
  • Careers
  • Contact

Pharma and Biotech Consulting

Antibodies / ADCs (2)

These selected case studies illustrate the scope of our work, the level of expertise we’re able to offer, and our consistent record of successful engagements.

  • Location:   Resources
  • Case Studies
  • antibodies adcs

Case Study Index

By Service Area

  • Business Development
  • Product Development
  • Strategy & Commercialization

By Functional Discipline

  • Asset Scouting
  • Business Strategy
  • Clinical Development
  • Due Diligence
  • Expert Witness
  • Launch Planning
  • New Product Planning
  • Opportunity Mapping
  • Partnering and deal-making
  • Pharma Licensing
  • Preclinical Development
  • Regulatory Affairs
  • Research and IP evaluation
  • Valuations

By Modality

  • Antibodies, ADCs
  • Cell Therapy
  • Drug Discovery Platforms
  • Gene Therapy
  • Immunotherapy
  • Microbiome Drugs
  • Peptides & Proteins
  • Radiopharmaceuticals
  • Small Molecules
  • Vaccines

By Disease Area

  • Autoimmune / Immunology
  • Cardiovascular
  • CNS
  • Digestive / GI
  • Fibrosis
  • Hematology
  • Oncology
  • Respiratory
  • All
  • Business Development
  • Product Development
  • Due Diligence
  • Strategy & Commercialization
  • Opportunity Mapping
  • Valuations
  • Regulatory Affairs
  • Clinical Development
  • Asset Scouting
  • New Product Planning
  • Research & IP evaluation
  • Business Strategy
  • Oncology
  • Partnering & deal-making
  • Central Nervous System (CNS)
  • Gene Therapy
  • Antibodies / ADCs
  • Healthcare Investing
  • Pharma Consulting
  • Autoimmune / Immunology
  • Hematology
  • Immunotherapy
  • Small Molecules
  • Respiratory
  • Biotech Consulting
  • Cardiovascular
  • DNA/RNA
  • Discovery Platforms
  • Vaccines
  • Cell & Gene Therapy
  • Cell Therapy
  • Digestive / GI
  • Fibrosis
  • Peptides & Proteins
  • Pharma Licensing
  • Technology Transfer
  • Preclinical Development
  • Radiopharmaceuticals
  • Launch Planning
  • CMC Consulting
  • Drug Repurposing
  • Microbiome
  • Clinical Development Strategy
  • Supply Chain
  • Expert Witness
  • Interim Chief Medical Officer
  • Virtual Biotech

BLA submission support for a novel antibody-based therapeutic

Challenge Our client was nearing the completion of a pivotal Phase III trial with a novel antibody-based therapeutic. The product was designed to delay recurrence in cancer patients with minimum...
Learn More
Previous
1 2

Reach out today

Speak with us about our pharma & biotech consulting services.

  • Our Services
  • Core Team
  • Consulting Network
  • Resources
  • Case Studies
  • Careers
  • Contact

Alacrita, UK, Europe & Asia
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608

Alacrita, US
One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.

© 2009 - 2025 Alacrita Holdings Limited

Privacy Policy | Pharmaceutical Consulting

Alacrita Life Science Consulting Alacrita Life Science Consulting